Finance

Lists
X43:FRA
Eupraxia Pharmaceuticals Inc
€6.50
+0.78%
(+0.050) 1D
Sep 4, 8:25:23 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for X43...
Open
€6.50
High
€6.50
Low
€6.50
Mkt. cap
673.60M
Avg. vol.
0.00
Volume
0.00
52-wk high
€7.40
52-wk low
€4.28
No. of employees
49
Open
€6.50
High
€6.50
Low
€6.50
Mkt. cap
673.60M
Avg. vol.
0.00
Volume
0.00
52-wk high
€7.40
52-wk low
€4.28
No. of employees
49
News stories
From web sources and news partners
About Eupraxia Pharmaceuticals Inc
CEO-
Employees49
Founded2011
HeadquartersVictoria, British Columbia, Canada
SectorBiotechnology
Websiteeupraxiapharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.42M
7.87M
11.17M
12.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.47M
8.30M
4.78M
5.30M
Operating expense
6.88M
16.16M
15.96M
18.10M
Total operating expenses
6.88M
16.16M
15.96M
18.10M
Operating income
-6.88M
-16.16M
-15.96M
-18.10M
Other non operating income
-
-
-
-
EBT including unusual items
-6.37M
-16.71M
-12.64M
-14.46M
EBT excluding unusual items
-6.37M
-16.71M
-12.64M
-14.46M
Income tax expense
-623.00
11.34K
13.90K
30.38K
Effective tax rate
0.01%
-0.07%
-0.11%
-0.21%
Other operating expenses
-
-
-
-
Net income
-6.36M
-16.71M
-12.65M
-14.49M
Net profit margin
-
-
-
-
Earnings per share
-0.19
-
-
-
Interest and investment income
180.18K
666.92K
1.07M
1.39M
Interest expense
-
-
-
-
Net interest expenses
180.18K
666.92K
1.07M
1.39M
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.84M
-16.11M
-15.90M
-18.02M
Gain or loss from assets sale
-
1.49K
-
2.70K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps